de Jong MJ, et al. – The authors assessed potential redistribution of unused injectors to prevent spillage of these costly drugs by evaluating the quality of transport and home storage through the proportion of injectors stored within the recommended temperature range (2°C–8°C) and acceptance of redistribution by patients. Within the recommended temperature range, only 1 in 8 biological injectors was stored during transport and home–storage. This limited redistribution of unused injectors, but also raised concern about drug effectiveness in immune mediated inflammatory disease (IMID)–patients.